First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects

Clinical trial NCT04521738 · COMPLETED

Trial details

NCT number: NCT04521738
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight Healthy Subjects

Start date: 2019-04-25
Primary completion: 2019-09-26
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.